# Lucely Cetina

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lucely-cetina/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,908 |
| Field | Endometrial and Cervical Cancer Treatments |
| h-index | 29 |
| i10-index | 57 |
| Last Known Institution | Instituto Nacional de Cancerología |
| OpenAlex ID | https://openalex.org/A5032456519 |
| ORCID iD | 0000-0003-2018-7338 |
| Works | 110 |

## Researcher papers

- [A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors](https://scholariq.org/papers/a-phase-ii-study-of-epigenetic-therapy-with-hydralazine-and-magnesium-valproate/)
- [Epigenetics of cervical cancer. An overview and therapeutic perspectives](https://scholariq.org/papers/epigenetics-of-cervical-cancer-an-overview-and-therapeutic-perspectives/)
- [A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes](https://scholariq.org/papers/a-phase-i-study-of-hydralazine-to-demethylate-and-reactivate-the-expression-of/)
- [A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results](https://scholariq.org/papers/a-double-blind-placebo-controlled-randomized-phase-iii-trial-of-chemotherapy/)
- [Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study](https://scholariq.org/papers/histone-acetylation-and-histone-deacetylase-activity-of-magnesium-valproate-in/)
- [Nutritional Assessment Tools for the Identification of Malnutrition and Nutritional Risk Associated with Cancer Treatment](https://scholariq.org/papers/nutritional-assessment-tools-for-the-identification-of-malnutrition-and/)
- [Radiosensitizers in cervical cancer. Cisplatin and beyond](https://scholariq.org/papers/radiosensitizers-in-cervical-cancer-cisplatin-and-beyond/)
- [A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation](https://scholariq.org/papers/a-phase-ii-study-of-multimodality-treatment-for-locally-advanced-cervical-cancer/)
- [Modern management of locally advanced cervical carcinoma](https://scholariq.org/papers/modern-management-of-locally-advanced-cervical-carcinoma/)
- [Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients](https://scholariq.org/papers/brachytherapy-versus-radical-hysterectomy-after-external-beam-chemoradiation/)
- [Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review](https://scholariq.org/papers/functional-foods-modulating-inflammation-and-metabolism-in-chronic-diseases-a/)

## Researcher topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)

## Researcher university

- [Instituto Nacional de Cancerología](https://scholariq.org/institutions/instituto-nacional-de-cancerologia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.